U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate. Inhalational anthrax is a rare disease that can occur after exposure to infected animals or contaminated animal products, or … Read more
288 cases of measles reported in 2014 in US and measles cases are growing – Measles is an acute, contagious viral disease, usually occurring in childhood and characterized by eruption of red spots on the skin, fever, and catarrhal symptoms. In US, since January, 288 cases of measles were reported and number is growing.
MERS cases spike to 339 in Saudi Arabia — 8 new MERS deaths take Saudi toll to 102 – The Saudi health ministry announced eight new deaths from the MERS virus on Sunday taking the kingdom’s death toll from the disease to 102. The number of recorded infections in the kingdom has risen to 339, it added.
UCSF study finds codeine often prescribed to children in U.S. emergency rooms, despite available alternatives – Despite its potentially harmful effects in children, codeine continues to be prescribed in U.S. emergency rooms. There is a need to change prescription behaviors to promote the use of better alternatives to codeine, such as ibuprofen or hydrocodone.
Venezuelan H1N1 flu outbreak has killed 17 and infected another 250, according to health sources – An outbreak of H1N1 flu has killed 17 people in Venezuela and infected another 250, private media and local authorities said on Monday. H1N1, often referred to as swine flu, was a flu strain that swept around in the world in a 2009/2010 pandemic.
FDA approves first anti-diarrheal drug for HIV/AIDS patients — Fulyzaq is the second botanical drug approved by the agency – The U.S. Food and Drug Administration approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.
Scientists to study the role genes play in treating TB – The University of Liverpool has been awarded funding to determine whether differences in our genes determine how patients respond to drugs used to treat Tuberculosis (TB) in Sub-Saharan Africa.
FDA approves first generic versions of Singulair to treat asthma, allergies – The U.S. Food and Drug Administration approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies.
FDA approves Belviq to treat some overweight or obese adults – Belviq (lorcaserin hydrochloride) is approved as an addition to a reduced-calorie diet and exercise, for chronic weight management. This obesity drug is approved by US FDA for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).
Treating acute sinusitis with antibiotic does not appear helpful – Treatment with the antibiotic amoxicillin for patients with acute uncomplicated rhinosinusitis (inflammation of the nasal cavity and sinuses) did not result in a significant difference in symptoms compared to patients who received placebo.